Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Curevo Raises $110 Million to Advance Amezosvatein Shingles Vaccine
-
Acronis 2024 ESG Report Highlights a Year of Commitment to Sustainability Growth, Cybersecurity Leadership, and Social Impact
-
Resilinc’s Sr Director, Christopher Benham, Named 2025 Pros to Know by Supply & Demand Chain Executive Magazine
-
EnBW International Finance B.V. - Annual Report 2024
-
Allarity Therapeutics Announces Presentation of Phase 2 Clinical Data from Ongoing Trial in Advanced Ovarian Cancer Patients at the 2025 Annual Meeting for the Society of Gynecologic Oncology
-
Signify share repurchase period update
-
Maxion Therapeutics Raises $72 million (£58 million) in an Oversubscribed Series A Financing to Advance its KnotBody® Pipeline and Platform
-
Sailing: curtain falls on the 'Virginie Hériot Trophy' at Yacht Club de Monaco
-
Sailing: curtain falls on the 'Virginie Hériot Trophy' at Yacht Club de Monaco
-
Wearable Devices Expands to Next-Gen Neural Interaction for Everyday Life After Securing Patent in the United States
-
Wearable Devices Expands to Next-Gen Neural Interaction for Everyday Life After Securing Patent in the United States
-
Goodfood Exercises Common Share Repayment Right in Respect of 2025 Debentures
-
Nevada Governor Lombardo Applauds FHLBank San Francisco’s $10 Million Affordable Housing Investment in the Silver State
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Bakkavor Group plc
-
Rekor Systems Provides Guidance on Financial Results and Updates on Operational and Management Realignments
-
Evome Medical Technologies Appoints Michael Dalsin as Chairman of the Board of Directors; Increases Size of Board to Six
-
American Tungsten Corp. Announces Intention to Commence Normal Course Issuer Bid
-
Open Lending Postpones its Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
-
Aptose Biosciences Meets Nasdaq Minimum Bid Price Compliance
-
ProKidney Reports Full Year 2024 Financial Results and Business Highlights
-
NFI subsidiary New Flyer secures two Maryland Transit Administration orders for a total of 117 low- and zero-emission Xcelsior® buses
-
Creative Realities Announces Reflect Settlement Agreement
-
Digi Power X Announces Nasdaq Ticker Symbol Change to DGXX
-
Auction result of Treasury Bills - RIKV 25 0521 - RIKV 25 0917
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Greencore Group plc
-
IREN Secures 2.75GW for Data Centers in West Texas with New 600MW Grid Connection Agreement
-
Navigator Gas Announces Completion of Acquisition of Three Handysize Liquefied Ethylene Gas Carriers
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Learning Technologies Group plc
-
Sprott Physical Copper Trust Announces Filing to List on NYSE Arca
-
SAIC Announces Fourth Quarter and Full Fiscal Year 2025 Results
-
Kraig Biocraft Laboratories Confirms Operations in Vietnam's Silk Production Hub, Lam Dong Province
-
Zenas BioPharma Appoints Lisa von Moltke, M.D., as Head of Research and Development and Chief Medical Officer
-
Holding(s) in Company
-
Travere Therapeutics Submits sNDA to FDA for Approval of FILSPARI® (sparsentan) for the Treatment of FSGS
-
Heineken Holding N.V. reports transactions under its current share buyback programme
-
Humanetics Selects Lifecore Biomedical to Deliver CDMO Services Supporting Development of BIO 300 for the Prevention of Acute Radiation Syndrome
-
Guardian Capital Announces March 2025 Cash Distributions for Guardian Capital ETFs
-
Microbix & ACPCC support efforts to eliminate cervical cancer in the Indo-Pacific
-
Ashland completes sale of Avoca business to Mane
-
Study Reveals Lack of Physician Oversight in Missouri Medical Spas, Raising Patient Safety Concerns from ASDSA
-
Americold Realty Trust, Inc. Declares First Quarter 2025 Dividend
-
K92 Mining Announces 2024 Q4 and Annual Financial Results – Record Quarterly Net Income, Operating Cash Flow, EBITDA, Metal Sold, Production and Recoveries; Annual Production, Cash Cost and AISC, Al
-
Orezone Gold Announces C$8.8 Million
-
Nurix Announces U.S. FDA Orphan Drug Designation Granted to Bexobrutideg (NX-5948) for the Treatment of Waldenström Macroglobulinemia
-
Sprott Physical Gold Trust Net Asset Value Reaches $10 Billion
-
Greenheart Gold Provides an Update on Its Exploration Projects in Guyana
-
Salary.com to Explore Pay Trends for 2025 and Beyond During This Week’s ADP Meeting of the Minds
-
Chicago Atlantic Real Estate Finance Declares Common Stock Dividend of $0.47 for the First Quarter of 2025
-
Bridger Aerospace Appoints Sam Davis Chief Executive Officer
-
EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
